Asset Details
Do you wish to reserve the book?
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
Do you wish to request the book?
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
2010
Overview
In this trial, patients with mild-to-moderate heart failure were randomly assigned to receive an implantable cardioverter–defibrillator (ICD) alone or an ICD plus cardiac-resynchronization therapy. Patients in the latter group had lower rates of death and hospitalization for heart failure.
The use of implantable cardioverter–defibrillators (ICDs) improves survival among patients who have New York Heart Association (NYHA) class II or III heart failure with left ventricular systolic dysfunction despite optimal medical therapy.
1
Cardiac-resynchronization therapy (CRT) improves symptoms of heart failure, quality of life, exercise capacity,
2
–
6
and left ventricular function
7
when used in patients with NYHA functional class III or ambulatory class IV heart failure with a wide QRS complex. CRT has also been shown to reduce mortality among patients not receiving an ICD.
8
However, studies have not shown a survival benefit of CRT in patients with NYHA class II . . .
Publisher
Massachusetts Medical Society
Subject
/ Biological and medical sciences
/ Cardiac Pacing, Artificial - adverse effects
/ Defibrillators, Implantable - adverse effects
/ Female
/ Heart
/ Heart Failure - classification
/ Heart failure, cardiogenic pulmonary edema, cardiac enlargement
/ Hospitalization - statistics & numerical data
/ Humans
/ Male
